Hemagglutination Inhibition Tests
-
Subject Areas on Research
- A Prevalent Focused Human Antibody Response to the Influenza Virus Hemagglutinin Head Interface.
- A seroepidemiological study of pandemic A/H1N1(2009) influenza in a rural population of Mali.
- Accelerated rejection of skin grafts in recipients sensitized with extracted human histocompatibility antigens.
- Cigarette smoking and hemagglutination inhibition response to influenza after natural disease and immunization.
- Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children.
- Comparison of glycoproteins isolated by phenol-water partition of human erythrocyte membranes.
- Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults.
- Development of a monoclonal antibody specific for serotype 3 rotavirus strains.
- Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3' proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity.
- Hereditary alterations in the immune response: coexistence of "agammaglobulinemia", acquired hypogammaglobulinemia and selective immunoglobulin deficiency in a sibship.
- Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
- Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older.
- Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.
- Impact of early life exposure to ionizing radiation on influenza vaccine response in an elderly Japanese cohort.
- Intra-seasonal antibody repertoire analysis of a subject immunized with an MF59®-adjuvanted pandemic 2009 H1N1 vaccine.
- Measurement of fibrinogen degradation products.
- Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009.
- Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants.
- Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study.
- Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents.
- Systems biology of vaccination for seasonal influenza in humans.
- The effect of antipyretics on immune response and fever following receipt of inactivated influenza vaccine in young children.
- The interaction of a series of hybridoma IgGs with reovirus particles. Demonstration that the core protein lambda 2 is exposed on the particle surface.
- Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot study.
- West Nile virus in Mexico: evidence of widespread circulation since July 2002.
- [The new approach to rubella in pregnancy].